Award Recipients
Explore companies recognized by BCC Research for measurable leadership, innovation, and market impact.
Categories
Covered
Program Year
Excellence in R&D Award
Amazon Web Services (AWS)
Executive Summary
Amazon Web Services (AWS) is recognized with the 2025 Excellence in R&D award in the cloud services category for its continued focus on driving innovation in cloud technology from research to scaled, enterprise-ready solutions. By its continued focus on core infrastructure, distributed systems, security, and cloud-native solutions, AWS has been able to leverage its research strengths into robust, high-performance, and scalable cloud solutions for various sectors.
Notably, AWS's R&D approach is centered on innovation, resilience, and security, with a focus on strong governance and improvement in its cloud offerings. Collectively, these successes reflect AWS’s persistence in providing strong, differentiated, and business-driven cloud solutions through excellence in R&D in 2025.
Why This Company
AWS excels in its long-term dedication to R&D in the cloud services space, unlocking deep technical innovation to produce highly reliable, scalable, and secure cloud platforms. AWS continues to push the boundaries of fundamental cloud infrastructure, distributed systems, and security technology, allowing customers from various sectors to develop and run business-critical workloads on a global scale.
The company also excels in its R&D efforts by executing them in a disciplined manner, allowing for the fast commercialization of innovations without sacrificing performance and resilience. The emphasis on security by design, operational excellence, and continuous optimization further cements AWS's key positioning in cloud services R&D excellence.
Excellence in Product Launch Award
Vertex Pharmaceuticals Incorporated
Executive Summary
BCC Research has announced its 2025 Excellence in Product Launch Award to Vertex Pharmaceuticals Incorporated. Vertex demonstrates its expertise in pharmaceutical commercialization through its recent successful launches, notably Casgevy (gene editing), Journavx (non-opioid pain management), and Alyftrek (next-generation cystic fibrosis treatment). Vertex Pharmaceuticals has shifted its identity from a cystic fibrosis-centric firm to a diverse biotech giant, recognized by the Excellence in Product Launch award. By prioritizing high-stakes R&D and aggressive portfolio diversification, Vertex Pharmaceuticals achieved a landmark "triple launch" year in 2025. This milestone saw the company successfully commercialize three transformative treatments spanning diverse therapeutic categories, including gene editing, respiratory diseases, and non-opioid pain relief.
Why This Company
Vertex's 2025 performance stands out as a rare achievement, successfully launching three potential blockbusters across three distinct therapeutic areas: Pain, Cystic Fibrosis, and Hematology. Vertex 2025 strategic innovations, defined by its portfolio diversification in collaboration with Moderna regarding VX-522, remain a cornerstone of Vertex’s mission to treat all patients with cystic fibrosis. During 2025, the partnership reached a critical juncture by releasing clinical data from the multiple ascending dose (MAD) segment of its Phase 1/2 investigations. A CRISPR-based gene-editing therapy has significant reimbursement agreements with NHS England (as of July 2025) and multiple European countries.
Excellence in Market Growth Award
Lilly USA LLC
Executive Summary
Lilly USA LLC. is nominated for the 2025 Excellence in Market Growth Award by BCC Research for exceptional market growth. The company became the first healthcare firm to reach a market capitalization of $1 trillion in 2025. It also achieved major expansion in the diabetes market and made a significant contribution with its cutting-edge metabolic portfolio. In 2025, the company recorded an impressive 94.2% year-over-year revenue growth during the first nine months for its primary product, Mounjaro, which strengthens its product portfolio and reflects its ability to scale innovative treatment solutions, improve patient access, and strengthen its competitive positioning in the diabetes care landscape.
The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the diabetes therapeutics domain using a combination of various indicators. These indicators, including manufacturing capacity, supply chain resilience, geographic expansion, product performance, and year-on-year revenue contribution of the product (diabetes), were applied to leading companies to assess their performance. Lilly demonstrated outstanding market growth within the diabetes therapeutics segment, driven by strong commercial execution and strategic expansion across key geographies. The company expanded patient access by launching its flagship diabetes therapy in key markets such as India, making its strategic shift to South Asia, and strengthening its distribution network through local partnerships.
Why This Company
Lilly USA LLC has been nominated for the Excellence in Market Growth award due to its impressive commercial success and significant operational growth. In 2025, Lilly recorded a 94.2% revenue increase across the first nine months of the year for its flagship incretin, Mounjaro (tirzepatide). In 2025, tirzepatide achieved strong adoption and became the most prescribed agent in its class in key markets. The drug captured a leading position in diabetes treatment prescriptions, reflecting broad clinician preference and accelerated market uptake.
Moreover, Lilly strengthened its industry position by proactively scaling its manufacturing capacity to meet rising global demand for metabolic therapies. The company’s strong investment in domestic and international production facilities reduced supply constraints, thereby supporting higher product availability across key regions. This capacity expansion contributed to sustained volume growth and increased market share in the diabetes and metabolic therapeutics segment.
Also, the company's ongoing investments in research and development for both early- and late-stage diabetes treatments are further driving its market growth.
Excellence in Market Growth Award
Amkor Technology (Amkor)
Executive Summary
Amkor Technology is recognized with the 2025 Excellence in Market Growth Award in the Outsourced Semiconductor Assembly and Test (OSAT) domain by BCC Research. This award reflects, company's strategic market position and its geographic expansion, together with its technological development in a vital and rapidly evolving sector. The company offers a broad advanced packaging portfolio, such as 2.5D, high-density fan-out, and system-in-package (SiP), that catered to a wider customer base and contributed to the company’s market growth. Also, the company has deep integration with key foundries and fabless players, along with a geographically diversified manufacturing footprint spanning the U.S., South Korea, Vietnam, Portugal, and other strategic locations.
The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the OSAT domain using a combination of various indicators. These indicators, including capacity and revenue expansion trends, geographic diversification, depth of advanced packaging capabilities, and strength of customer ecosystems, were applied to leading OSAT companies to assess their performance. Amkor reported approximately 31% sequential revenue growth in Q3 2025, driven largely by increased demand for advanced packaging solutions linked to artificial intelligence (AI) and high-performance computing (HPC) programs.
Why This Company
Amkor established its position as the key market player while expanding its business operations, as it operates advanced packaging facilities as a U.S.-based OSAT company in various locations outside of Taiwan and China. The company built its manufacturing operations across South Korea, Vietnam, Portugal, and Arizona, the U.S., to meet customer demand for supply chain resilience.
Also, the company engages deeply with key players such as TSMC, Apple, NVIDIA, and Infineon, demonstrating broad ecosystem prominence across mobile, computing, automotive, and consumer markets. With a comprehensive advanced packaging platform including 2.5D, high-density fan-out, system-in-package (SiP), advanced flip chip, and next-generation S Connect, the company enables multi-platform customer support. The company differentiated itself from competitors that are primarily concentrated in Taiwan or offer more limited technological portfolios.
Excellence in Sustainable Innovation Award
Bloom Energy
Executive Summary
Bloom Energy is being presented with the 2025 Excellence in Sustainable Innovation Award for successfully transforming advanced solid-oxide technology research into commercially scalable, low-emission fuel cell systems. Celebrating its 25th anniversary in 2026, the company successfully transitioned its initial fuel cell system research to the early commercialization stage deploying small scale systems at commercial and industrial locations. Now, the company offers a variety of power generation and hydrogen solutions deployable across industries globally, including increasingly larger solutions for commercial and industrial, utility and data center customers.
Bloom has been at the forefront of energy innovation for more than two decades, providing alternatives to centralized energy. It designs, manufactures, distributes, and operates the Bloom Energy Server to provide resilient, distributed power for critical operations. It has driven sustainability innovation and excellence through deployments of advanced microgrids reducing the need for backup generation, hydrogen systems capable of producing zero carbon power, and combined heat and power solutions delivering both high efficiency power generation and useful heat to support building operations. It’s ability to deploy large scale non-combustion power generation solutions quickly to support the rapid growth of digital infrastructure set it apart from the competition and help enhance the sustainability and competitiveness of both industry and communities alike.
Why This Company
Bloom Energy has established itself as a key player in the fuel cell systems domain through its strong determination for sustainability. The company has commercialized a large and expensive electrochemical research program with advanced materials science. This has enabled low-emission, ultra-reliable power for larger applications. Constant focus on SOFC technology has contributed to the company’s current position as a prominent player in the development of clean, reliable, and resilient power generation systems that provide significantly lower emissions compared to traditional power generation equipment. It addressed real-world sustainability challenges alongside enterprise-grade performance and reliability.
The company’s long-term strategy focused on lifecycle efficiency, modularity for scaling production, and continuous optimization of gains to embed sustainability in manufacturing, deployment, and operation. It has expanded fuel cell deployment around the world, including data centers, hospitals, utilities, and industrial users.
Excellence in Operational AI Award
Schneider Electric
Executive Summary
Schneider Electric stands out in Operational AI excellence in the energy sector by embedding artificial intelligence at the core of its sustainability and business strategy. Through its EcoStruxure architecture and platform, Schneider has industrialized AI across predictive maintenance, energy optimization, process efficiency, and asset lifecycle management, delivering measurable and repeatable sustainability outcomes at global scale.
Real-world deployments demonstrate this impact, where Schneider’s AI-powered EcoStruxure Asset Advisor and EcoCare services use predictive analytics and continuous monitoring to extend asset life, reduce unplanned downtime, and cut maintenance-related emissions across grids, substations, and energy-intensive industrial assets. In industrial applications, EcoStruxure Industrial Advisor – Predictive Energy has enabled customers to reduce energy consumption by up to 10% and associated carbon emissions by as much as 40%, with ROI often achieved in under six months.
Beyond operations, Schneider integrates sustainability across the full product lifecycle with digital twins, circular economy design, refurbishment, and AI-driven energy efficiency aligning with its corporate goal of helping customers save and avoid 800 million tonnes of CO₂ emissions by 2030. Critically, these AI innovations are commercially viable, scalable, and profitable, underpinning long-term growth.
Why This Company
Schneider Electric has moved AI from experimentation to industrial-scale execution, embedding it across the entire energy value chain through its EcoStruxure platform. Schneider delivers measurable, repeatable outcomes using AI-driven predictive maintenance, energy optimization, and digital twins to cut energy losses, extend asset life, reduce carbon emissions, and lower operating costs while improving reliability. Crucially, these sustainability gains are not isolated pilots but profitable, scalable business models adopted globally by utilities, data centers, and energy-intensive industries, setting a new benchmark for how Operational AI can simultaneously drive decarbonization and long-term enterprise value.
Excellence in Strategic Execution Leadership Award
Valero (VLO)
Executive Summary
Valero stands out as a strategic market visionary in the sustainable energy industry by maintaining its leadership in the biofuel industry. The company exemplifies its dominant position in strategic execution leadership through its business expansion in the biofuel industry, strong financial position, and disciplined supply chain operations amid various challenges like limited feedstock supply, high cost, intense competition, and trade policies. It has achieved record refining throughput of 3.2 million barrels per day at its 15 refineries spanning across the U.S., the U.K., and Canada. It has also successfully maintained safety standards while advancing low-carbon fuels like sustainable aviation fuel (SAF) and renewable diesel.
The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated various companies working in the biofuel domain using a combination of various indicators. These indicators, including capacity expansion trends, execution efficiency of capital expenditure, sustainability throughout the operations, and key milestones achieved, were applied to leading biofuel companies to assess their performance. Valero reported an exceptional 95% plant utilization rate in Q4 2025, driven largely by strong throughput records and profitability margins in biofuel business segments.
Why This Company
Valero has been selected for the Excellence in Strategic Execution Leadership Award for its ability to deliver biofuel projects on time, maintain profitability despite challenges, optimize capital, and ensure sustainability across its operations. While maintaining profitability, it is also exploring other ventures, such as CCUS, the benefits of IRA tax credits, and surpassing its peer groups. Despite its exit from California (Benicia refinery), the company benefits from the One Big Beautiful Bill Act (OBBBA) through increased clean energy incentives. Also, strong leadership teams, such as the newly appointed COO and CEO, are driving Valero to position itself at the top of the biofuels industry.
Excellence in Sustainable Innovation Leadership Award
Xylem
Executive Summary
Xylem stands out in the Sustainable Innovation Leadership award in the advanced material sector, with a focus on the water treatment and management market. It shows exceptional performance in the sustainability segment across various fronts, including strong innovation economics, scalable operating models, and plausible climate leadership. It sets the benchmark for other peers in the water industry on how sustainable innovation can deliver environmental, social, and economic value on a global scale.
The environmental impact justified by the company’s strategic initiative towards establishing 1.5°C-aligned Science-Based Targets covering Scope 1, 2, and 3 emissions, validated by the SBTi in 2024, with a commitment to net-zero by 2050. The company’s R&D investment of more than $200 million annually, along with digital integration and strategic acquisitions such as Idrica, is strengthening its Xylem Vue platform, further positioning the organization at the forefront of next-generation water technologies. Sustainability-based financing decisions directly impact the environmental performance of capital and shape the financial strategy. The company's sustainability leadership is further supported by science-based climate commitments, policy engagement, and partnerships that impact standards across the water sector.
Why This Company
Xylem identified as an industry leadership within a single, water-focused business model. Unlike diversified conglomerates, where water is one of many verticals, Xylem’s core purpose and revenue source are water, ensuring strategic investment and a long-term commitment to the sector. The company does not treat sustainability as a government-mandated regulation; instead, it integrates it directly into product design, digital platforms, financing structures, and customer outcomes.
Excellence in New Product Innovation
AUO Corp.
Executive Summary
AUO Corp. is nominated for the 2025 Excellence in New Product Innovation Award in the display components category by the BCC Research. This award highlights the company's strategic initiative in line with the integration of next-generation display technologies, particularly in the MicroLED and organic light-emitting diode (OLED) technology, advancing them from prototype validation to market-ready demonstrations. The company offers a broad range of transparent display solutions, including MicroLED transparent display panels, modules, and digital cockpit solutions that deliver high transparency and ultra-bright brightness of over 1,000 nits and more. Also, the company offers various integrated transparent display solutions under their SeeThrµ series, including transparent displays with over 60% transparency, suitable for retail, commercial, and automotive applications.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as cross-industry applicability, depth of display technology integration, and diversification in end-use applications were analyzed across the display solutions and component manufacturers. In line with this, the AUO Corp. showcased its various novel transparent display solutions, ranging from display panels to modules. One such example is AUO Corp.'s 17.3-inch dual-sided transparent MicroLED display showcased in 2025. The company, with its innovative display technology, provided a dual interactive transparent solution to overcome the issues of space and transparency.
Why This Company
AUO Corp established itself as a prominent player within the display components category. This positioning is based on the company's advanced strategic product innovation within the transparent MicroLED displays. In 2025, the company offered its integrated display solutions and components for automotive HUD, retail signage, and museum and exhibition display applications. Its transparent display is claimed to have delivered a high transparency rate with over 1,000 nits of brightness, catering to the needs of high-end applications in commercial settings.
In 2025, AUO Corp. showcased the capabilities of its integrated display solutions and components to deliver enhanced and impactful user experiences. Through its application integration capabilities, the see-through display technology offered over 60% transparency, a dual-sided transparent Micro LED display, and a 42-inch single-module transparent panel that overcame the limitations of traditional 12-inch prototypes. By emphasizing innovative HUD and display panel solutions, the company differentiated itself from competitors.
Excellence in Product Launch
BASF
Executive Summary
BASF has been nominated for the Excellence in Product Launch Award for demonstrating strong commercialization discipline by systematically converting R&D outputs into polymer and advanced-material solutions aligned with trends such as electrification, lightweighting, and circular-economy plastics. In the first 9 months, ending September 2025, BASF invested around $1.7 billion in research and development, leading to the launch of various new products. Furthermore, BASF filed 1,159 new patents, roughly 45% of which were focused on sustainability. BASF's integrated Verbund production model enables rapid industrialization of new grades by leveraging shared intermediates, utilities, and infrastructure, reducing scale-up risk compared with stand-alone specialty producers. Rather than pursuing high-volume launches, BASF focuses on targeted, application-specific introductions with OEMs, resulting in longer product lifecycles and stronger margin retention.
The award nomination is supported by a structured evaluation framework emphasizing market understanding and commercialization, strategies, execution discipline, and innovation scalability. BASF demonstrates measurable success through sustained sales contributions from recently introduced products, strong patent activity in sustainable and high-performance materials, and co-development partnerships with OEMs and converters that accelerate qualification and adoption. Independent benchmarking highlights BASF's ability to couple scientific innovation with industrial readiness, supported by cross-functional collaboration among research, application engineering, and production teams.
Why This Company
BASF has been nominated for the Excellence in Product Launch Award for its ability to consistently translate materials science innovation into commercially scalable solutions across engineering plastics, performance polymers, and sustainable chemistry platforms. Central to this achievement is BASF's innovation-driven strategy, which aligns research, application engineering, and production through its integrated Verbund model. By integrating product design, pilot validation, and large-scale manufacturing within a unified value chain, BASF enables faster industrialization of new materials while maintaining cost efficiency, supply reliability, and consistent quality. This integrated approach allows customers to adopt advanced materials more rapidly and transition toward lighter, more sustainable, and performance-enhanced applications.
Operationally, BASF distinguishes itself through disciplined commercialization and measurable innovation impact. In the first 9 months, ending September 2025, BASF invested around $1.7 billion in research and development, leading to the launch of various new products. Its structured innovation governance, supported by global research networks, application testing centers, and close customer integration, ensures that new grades of polymers, additives, and formulated systems are market-validated prior to scale-up. BASF's production network further supports launch reliability by leveraging shared raw materials, energy integration, and logistics infrastructure, enabling efficient global replication of successful products.
Excellence in Sustainable Innovation
Daikin Industries Ltd.
Executive Summary
Daikin Industries Ltd. is nominated by BCC Research for the 2025 Excellence in Sustainable Innovation Award in recognition of its notable contributions toward achieving carbon-neutral targets across its business verticals and its continued commitment to carbon reduction and sustainability-driven innovation. For instance, as of June 2025, three manufacturing plants of Daikin Industries, including Daikin Air-Conditioning (Shanghai) Co., Ltd., the Rinkai Factory at the Sakai Plant, and Daikin Rexxam Electronics Co., Ltd., had reached the goal of net-zero GHG (Greenhouse Gas) emissions, well ahead of the corporate schedule (which is planned by 2030). Also, the company has a strong focus on sustainable innovation, such as energy-efficient technologies, and shifting to low-GWP refrigerants.
The methodology included market scanning to identify companies from the refrigeration and cooling domain. Upon identification of the companies, the analyst performed a competitive benchmarking exercise to assess peer performance across diverse parameters, such as energy efficiency, transition to green refrigeration, and priority for innovative sustainable practices in the refrigeration equipment industry. Based on this assessment, Daikin Industries was selected for further evaluation. The company was then evaluated based on core performance metrics, like environmental impact, business viability, innovation quality, circular economy integration, and ESG governance, including climate risk management at the board level and sustainability-relevant factors.
Why This Company
Daikin Industries Ltd. has been offering low-carbon technologies that deliver energy-efficient refrigeration solutions through low-GWP refrigerants. Such prudent developments significantly reduced GHG emissions and helped it achieve global climate goals. Daikin offers integrated commercial refrigeration units that combine inverter-driven compressors and advanced controls for higher energy efficiency, helping the company increase sustainable efficiency by reducing GHG emissions. The ongoing initiatives to incorporate sustainable initiatives helped the company accelerate its advanced technologies/products and achieve sustainable practices. For instance, in November 2025, at the inaugural HVACR World event in the UAE, Daikin Industries announced its silver sponsorship, an event that enhances brand visibility and improves networking opportunities.
In addition, the company offers commercial refrigeration solutions that have high recycling capabilities, which help reduce waste and extend product lifespan. These products also used low-GWP refrigerants and featured energy-efficient designs that influenced the global commercial refrigeration industry.
Excellence in Innovation Barrier Breaker
Gilead Sciences Inc.
Executive Summary
Gilead Sciences Inc. is nominated for the 2025 Excellence in Innovation Barrier Breaker Award by BCC Research for fundamentally reshaping the HIV prevention paradigm. Gilead Sciences is a biopharmaceutical company active in HIV care, advancing long-acting therapies to address unmet needs in treatment as well as prevention. In June 2025, the company introduced a first-in-class capsid inhibitor, Yeztugo (lenacapavir), with twice-yearly dosing. This innovative drug aided in breaking down barriers that had long defined traditional HIV prevention methods and helped overcome challenges related to therapy adherence and stigma, thereby making prevention more accessible for vulnerable and high-risk populations at a wider scale.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as first-in-class scientific novelty, dosing frequency disruption Index, and patient and community preference validation were analyzed across the HIV prevention drug companies. In line with this, Gilead Sciences Inc. demonstrated that innovative drugs can be delivered to the world’s most vulnerable population at the same time they are introduced in the developed part of the world. For instance, Yeztugo operates outside all currently approved antiviral classes, resetting the scientific benchmark, altering competitive strategy, and redefining the future standard of care in HIV prevention.
Why This Company
Gilead Sciences Inc. received the U.S. FDA approval for the world's first twice-yearly injectable HIV pre-exposure prophylaxis (PrEP), Yeztugo (lenacapavir), in June 2025. By winning a single regulatory approval, it was able to simultaneously exceed several structural limitations that had long defined the limits of HIV prevention: the pharmacological challenge of targeting the capsid, the behavioral barrier of therapy adherence, the clinical bottleneck of maximum achievable efficacy, the population-access barrier for underserved high-risk communities, and the systemic barrier of delayed access in low-income countries.
Building on this momentum, the company moved quickly to translate innovation into equitable distribution. For instance, in July 2025, Gilead Sciences, Inc. partnered with the Global Fund to Fight AIDS, Tuberculosis, and Malaria to supply lenacapavir on a not-for-profit basis, providing enough doses to reach up to two million people in eligible low-income countries over three years. With the launch of Yeztugo, it has been able to successfully break several long-standing barriers that have traditionally limited the reach and impact of HIV prevention.
Excellence in Market Strategy
Medtronic
Executive Summary
BCC Research has nominated Medtronic for the 2025 Excellence in Market Strategy award for its market transition strategy, which aimed to reshape the standard of care in the cardiovascular therapeutic area, such as cardiac rhythm management. The company refocused its efforts from growing competition within traditional transvenous implantable cardioverter defibrillator (ICD) systems to increasing use of extravascular and physiological pacing platforms as the next phase of cardiac rhythm management. It is an important strategic move as it positioned Medtronic to shape the future direction of cardiac rhythm management, guiding the market toward minimally invasive, and strengthening its long-term competitive position. For instance, at the European Society of Cardiology (ESC) in September 2025, Medtronic used real-world information along with current clinical data outcomes to strategically strengthen an extensive move towards physiological pacing and extravascular defibrillation as the next standard of care.
The approach of the award assessment is based on a structured research methodology across the cardiovascular device landscape, starting with a logical market scanning of regulatory, clinical, and commercial developments, followed by the shortlisting of prominent players. Extensive analysis has been conducted for the selected company to portray how the company aligned clinical validation, regulatory sequencing, and geographic rollout to support a defined cardiovascular market strategy. For instance, in 2025, the company advanced its market strategy by leveraging regulatory clearances to expand the commercial deployment of Micra AV2 and Micra VR2 leadless pacemakers, supporting a careful shift away from conventional transvenous pacing systems.
Why This Company
In 2025, Medtronic implemented a planned strategy to reposition its cardiovascular devices portfolio. The company focused on minimally invasive, physiological device designs instead of competing in traditional transvenous pacing and defibrillation markets. Medtronic paced up the adoption of leadless pacemakers and extravascular ICD (implantable cardioverter-defibrillator) platforms. By adopting this approach, the company aimed to establish long-term clinical standards and reduce reliance on older lead-based systems. This shift reflected a strategic effort to reshape therapy pathways rather than simply maintain existing market share.
Within the structural heart and electrophysiology segments, the company executed a coordinated market strategy by aligning clinical validation timelines, regulatory sequencing, and targeted geographic prioritization to support a defined marketing strategy objective. By integrating implantable devices, catheter-based therapies, and monitoring capabilities into a combined cardiovascular pathway, the company strengthened its strategic positioning and reinforced cross-segment influence over therapy selection patterns within hospital systems.
Excellence in Digital Transformation Award
Siemens
Executive Summary
Siemens AG has been nominated for the 2025 Excellence in Digital Transformation Award in industrial automation based on strong evidence of enterprise-wide digital leadership that integrates strategy, technology, and operational execution. Its FY-2025 Siemens highlights record performance linked to software-and-services-driven growth model and the CEO-led ONE Tech operating framework, which unifies automation, software, and data capabilities across business units. This governance and operating structure have enabled Siemens to embed digitalization systematically into core processes, rather than treating it as a peripheral innovation initiative.
The award nomination is framed around a structured, evidence-based evaluation model that integrates market scanning, shortlisting, in-depth organizational analysis, and a weighted scoring framework to assess enterprise-wide digital transformation maturity. BCC Research emphasized transformation scope, technology integration, business results, change leadership, and sustainability impacts. The framework is supported by both quantitative KPIs and qualitative governance and cultural indicators, validated through peer benchmarking, independent third-party recognition, and documented customer outcomes, thereby ensuring that Siemens’ nomination is based on verifiable performance.
Why This Company
Siemens has been nominated for the Excellence in Digital Transformation Award for its ability to integrate digital innovation with industrial engineering. Central to this achievement is the company’s strategy of converging physical and digital environments through its Xcelerator platform and a comprehensive Digital Twin ecosystem. By linking design, simulation, validation, and production optimization across product and manufacturing lifecycles, Siemens has enabled customers to accelerate development cycles and transition toward adaptive, data-driven operating models.
Operationally, Siemens distinguishes itself through large-scale deployment and measurable outcomes. Its Electronics Factory Erlangen, designated as a World Economic Forum Global Lighthouse, demonstrates substantial productivity (e.g., 69% productivity gains and 42% energy reductions) enabled by digital twins and advanced automation. Moreover, Siemens has commercialized integrated digital platforms, including MindSphere, Mendix, and Xcelerator, to accelerate sensor-to-application workflows.
Additionally, Siemens has demonstrated strong impact through ecosystem leadership and measurable customer outcomes. High-profile industry engagements, including collaborations with NVIDIA, have reinforced its role in advancing AI-enabled automation in real-world industrial settings. These initiatives have resulted into tangible performance improvements, with Customers leveraging Siemens’ Digital Twin Composer and Industrial AI technologies reporting up to 20 % increases in throughput. These results illustrate Siemens’ ability to convert advanced digital capabilities into sustained operational efficiency.
Excellence in Technology Integration Award
Stryker
Executive Summary
BCC Research has nominated Stryker for the 2025 Excellence in Technology Integration award for its ability to integrate multiple orthopedic surgical robotic technologies through a single, advanced robotic architecture. In March 2025, Stryker launched MAKO 4, its fourth-generation single system, which pushed the boundaries of orthopedic robot technology. It combines next-generation haptic feedback and 3D CT-based planning, which allows surgeons to plan the implant size and precise positioning before the surgery. The newly launched MAKO Shoulder includes Tornier implants, Blueprint planning software, and Mako Smart Robotics, which offers haptically guided preparation for Tornier to perform a reversed glenoid. The integration of high-fidelity spatial mapping enables the system to dynamically scale its capabilities. This allows surgical teams to transition effortlessly from large-joint procedures to the high-precision requirements of shoulder and spine surgeries.
The award selection criteria are based on a systematic, multi-parameter approach to technology integration evaluation. The assessment focused on different technology integration-related parameters, such as surgical accuracy, workflow efficiency, platform evolution, and technology-integrated clinical scalability. By the end of December 2025, Stryker had supported over 2 million robotic procedures across Mako Total Knee, Mako Total Hip, and Mako Partial Knee, and over 1 million robotic Mako Total Knee procedures in 45 countries worldwide, demonstrating Internal Review only, unlicensed copy technology-integrated clinical scalability and solidifying robotic-assisted joint repair as a standard of care.
Why This Company
In 2025, Stryker achieved major advancements in the complex technological integration of surgical robots for orthopedics. The company introduced Mako Total Hip with Advanced Primary and Revision, which allows for intraoperative screw trajectory guidance, augment and screw planning, and compatibility with its revision hip implant line. This is supported by technologies such as blueprint planning software and spine guidance software. Stryker's fourth-generation Q Guidance System includes the FP8000 camera, which offers faster, full-spectrum active/passive hybrid optical tracking. The Mako 4 system is a single robotic system that encompasses total hip, total knee, partial knee, and spine applications, which increases workflow efficiency when compared to manual procedures.
In order to further improve surgical accuracy, Stryker combined robotic, digital, and AI technologies. Accurate implant alignment, CT-based 3D patient-specific planning, and uniform protocols across several operations are a few instances of platform innovation. The combination of modular hardware, AI-based digital tools, and smart surgical software is supported by approvals like the U.S. Food and Drug Administration's 510(k) clearance for total hip with Advanced Primary and Revision in 2025. It is also seen in Stryker's 2025 introduction of Mako Shoulder, which unifies Mako SmartRobotics, Blueprint planning software, and Tornier implants into a single platform.
Excellence in Technology Integration Award
ABB
Executive Summary
ABB is recognized with the 2025 Excellence in Technology Integration Award in the smart manufacturing domain for advancing technology integration. ABB is primarily known for creating a plug-and-produce ecosystem. In 2025, ABB achieved technological integration by effectively integrating advanced robotics with AI-powered digital twins, ensuring seamless connectivity between edge devices and the cloud. By breaking down long-standing data silos and integrating traditional physical assets with modern software, the company enabled manufacturers to transition from rigid, monolithic production lines to highly adaptable, modular microfactories. For instance, in August 2025, ABB collaborated with Cosmic Buildings to deploy mobile robotic microfactories in response to the wildfires in Southern California. These units successfully cut building time by 70% by combining ABB IRB 6710 robots with RobotStudio digital twin software to fabricate modular dwellings on-site.
The award selection process followed a standardized three-step methodology that prioritized excellence in technology integration within the smart manufacturing sector. After identifying companies through a thorough market scan, the analyst conducted a competitive benchmarking exercise to assess peer performance against international architectural standards. The selected company, ABB, was thoroughly scored based on its capacity to create high-performing, integrated digital ecosystems and to deliver quantifiable efficiency gains. The award highlights ABB's tangible impact on the smart manufacturing industry, especially in 2025, through its ability to improve operational excellence by at least 30% with technology integration, while significantly reducing capital expenditure.
Why This Company
ABB's successful integration of diverse industrial data streams through the ABB Ability Genix Industrial AI Suite was the primary factor in its selection as the 2025 Excellence in Technology Integration award winner. The organization successfully removed gaps that had previously impeded industrial productivity by bridging the gap between Information Technology (IT), Operational Technology (OT), and Engineering Technology (ET).
With the release of Genix Copilot in December 2024, a generative AI assistant based on the Azure OpenAI Service, this integration was further enhanced, enabling engineers to communicate with complex real-time data using natural language. Organizations were able to anticipate equipment failures with previously unheard-of precision through this seamless communication, thereby drastically reducing troubleshooting time across many industries.
ABB's performance was also demonstrated by its ability to convert integrated data into quantifiable sustainability outcomes, going beyond operational speed. Integrations, such as the partnership with E.ON to implement environmentally friendly, gas-insulated switchgear in July 2025, demonstrated that ABB's technology was a scalable, worldwide solution rather than just a local invention. The company has demonstrated that combining advanced AI with deep-domain industrial knowledge could both improve productivity and encourage the shift to a net-zero future.
Excellence in New Product Innovation Award
PPG Industries, Inc.
Executive Summary
PPG Industries Inc. has been nominated for the New Product Innovation award in the coating sector, with a focus on the non-methanol hard coating, two-coat powder systems, and sustainable coatings technologies. It shows exceptional performance in the product innovation segment across various fronts, including scientific research, patent applications, marine coatings, and low-VOC waterborne coatings. It sets the benchmark for other peers in the coating industry on how product innovation can build new business opportunities in the developing world.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. BCC Research evaluated various companies working in the coating domain using a combination of various indicators such as technological novelty, patent position, application efficiency growth in end use, AI/ML integration, and bio-based content were used to evaluate companies. The analysis was further based on the government publication and availability of public disclosures, sustainability reports of key players, and deployment data of coatings. PPG Industries Inc.’s long-term strategy focused on sustainable raw materials, energy-efficient technologies, and consumption of post-industrial recycled plastic along with constant focus on emerging coating technologies has contributed to the company’s current position as a prominent player in coating innovation compared to traditional players.
Why This Company
PPG Industries Inc. has established itself as a key player in the coating domain through its strong, diverse technologies and innovation. The company has commercialized a large and expensive coating technology with advanced materials science. PPG Industries Inc. delivers disruptive product innovation with noticeable commercial impact in the global market. It is embedding sustainability into product design, creating scalable customer-centric coating technologies, and leveraging AI and ML technologies to revolutionize its product development processes. It has strategically launched its coating technologies in defense, aerospace, marine, EVs, and healthcare businesses.
In September 2025, PPG Industries Inc. launched the PPG HI-GARD Non-Methanol hard coating for 1.5 standard index ophthalmic lenses. This scientific innovation meets the government standards and consumer expectations. Moreover, the growing trend of the circular economy and strict norms on carbon emissions, PPG Industries Inc. has developed an innovative technology to produce powder coatings with recycled plastics. In May 2025, PPG Industries Inc. launched ENVIROLUXE Plus powder coating technology, which consumes up to 18% post-industrial recycled plastic (rPET) and is developed without (Per- and Polyfluoroalkyl Substances) PFAS. The strategic new product innovation is further positioning the organization at the forefront of next-generation coating technologies. The company's new product innovation leadership is further supported by AI-Powered R&D, customer-centric applications, and battery coating technologies that impact standards across the coating sector.
Excellence in Generative AI Application
Abridge AI, Inc.
Executive Summary
Abridge AI, Inc. is nominated for the 2025 Excellence in Generative AI Applications Award by BCC Research for reshaping clinical documentation workflows through advanced generative AI technology. Abridge AI, Inc. is a healthcare technology company that creates generative AI-powered clinical documentation platforms to help clinicians deal with growing administrative burdens and inefficiencies associated with manual medical documentation. In 2025, the company expanded its platform deployment across multiple healthcare systems. For instance, in February 2025, Inova Health System deployed the Abridge platform across several specialties. This allowed over 1,000 Inova clinicians to provide better service to patients.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as clinical workflow impact, strategic partnerships, and integration with the EHR ecosystem were analyzed across the companies providing generative AI solutions for clinical documentation and ambient medical scribing. In line with this, Abridge AI, Inc. demonstrated high financial momentum to scale its AI platform. For instance, the company secured a funding round in February 2025 of a $250 million Series D investment led by Elad Gil and IVP, with participation from investors including Bessemer Venture Partners, CapitalG, CVS Health Ventures, and NVentures.
Why This Company
Abridge AI, Inc. developed a generative AI platform that turns clinician-patient conversations into structured medical notes in real time to help healthcare providers reduce administrative tasks and improve documentation efficiency. By integrating contextual AI models and clear “Linked Evidence” features, the company improves documentation accuracy to about 95%. Clinicians can also check AI-generated outputs against the original conversations. Physicians using Abridge reported up to 70% reduction in documentation time.
Furthermore, in 2025, Abridge showed strong market growth through quick enterprise adoption in leading healthcare systems, partnerships with major health organizations, and significant investor support that accelerated the development of its AI platform. It captured 30% market share very quickly despite being a startup competing with Microsoft. In addition, the platform is used by large health systems such as Johns Hopkins, Kaiser Permanente, Duke Health, and Mayo Clinic. The company solidified its position in the industry by receiving notable recognition, including best in KLAS for Ambient AI, which highlights its market penetration in AI-driven clinical documentation solutions.
Excellence in Innovation Barrier Breaker
Jazz Pharmaceuticals Inc.
Executive Summary
Jazz Pharmaceuticals Inc. is nominated for the 2025 Excellence in Innovation Barrier Breaker Award by BCC Research for fundamentally transforming pediatric oncology therapy. The company demonstrated innovation in pediatric oncology with Modeyso, the first targeted systemic therapy for Recurrent H3 K27M-mutant Diffuse Midline Glioma, launched in August 2025. This innovative drug breaks barriers by addressing brain tumors with very poor prognosis and historically limited treatment options, where patients mainly relied on radiation therapy and had no effective chemotherapy, targeted therapy, or immunotherapy available.
The award assessment was based on a structured research method and process that combined market scanning, peer benchmarking, and scoring-based validation. Most significant factors, such as therapeutic breakthrough impact, the severity of unmet medical needs, and the pediatric suitability index, were analyzed across pediatric oncology companies. In this regard, Jazz Pharmaceuticals has developed the first and only approved treatment for diffuse midline glioma with H3K27 M mutation, an ultra-rare and highly aggressive brain tumor caused by a mutation that disrupts epigenetic regulation and drives tumor growth.
Why This Company
Jazz Pharmaceuticals introduced innovative drug Modeyso (dordaviprone) in August 2025, the first and only approved therapy for H3K27M-mutant diffuse midline glioma, a rare and aggressive brain tumor affecting children and young adults with a historically poor prognosis and limited treatment options. The breakthrough therapy also offers a convenient, once-weekly oral administration that provides a child-friendly delivery approach while addressing a major therapeutic gap. In addition, the company's pediatric oncology pipeline showcases a continued commitment to advancing treatments for rare and difficult-to-treat childhood cancers.
Building on this momentum, the company broke barriers as the first and only to bring an approved therapy for H3K27M‑mutant diffuse midline glioma, a highly aggressive pediatric brain tumor with historically poor outcomes. The company’s efforts to address longstanding therapeutic gaps in pediatric oncology are reflected in the early adoption and continued development of its therapy for a rare and aggressive pediatric brain tumor. In FY 2025, the therapy generated $48.0 million in net product sales, indicating initial market uptake. Progress in advancing this treatment area was supported through the acquisition of Chimerix, which included $905.4 million in acquired in-process R&D, while the therapy’s dual-mechanism approach targeting disease biology and ongoing trials exploring use in newly diagnosed patients demonstrate continued development in this challenging domain.
Excellence in Product Launch
Lam Research
Executive Summary
Lam Research is nominated for the 2025 Excellence in Product Launch award in the semiconductor fabrication equipment domain by BCC Research. The award recognized the company's performance in the product launch process, including the degree of innovation in newly introduced products and the extent to which these products achieved confirmed customer adoption. For instance, in February 2025, the company introduced an etching system named Akara and announced that it was selected as the tool of production for multiple applications related to advanced planar dynamic random-access memory (DRAM) and foundry gate-all-around (GAA), a confirmation that showed the achievement of market adoption within the launch process itself rather than after it.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as confirmed customer adoption during the product launch, advanced node alignment for next-generation manufacturing across GAA, DRAM, and 200+ layer NAND transitions, and the presence of customer endorsements during the product's official launch were analyzed across semiconductor fabrication equipment manufacturers. In line with this, in February 2025, Lam Research introduced the ALTUS Halo molybdenum atomic layer deposition (ALD) platform, which entered high-volume manufacturing (HVM) at 3D NAND manufacturers in South Korea and Singapore and at advanced logic fabs.
Why This Company
Lam Research demonstrated strong execution of product launch through the introduction of novel technologies across various semiconductor fabrication process categories, such as etching, ALD, and patterning, in 2025. This multi-category launch strategy required in-line go-to-market execution across different engineering and product teams in the manufacturing of advanced semiconductor technologies.
An important indicator of launch performance was the adoption of Lam Research's Aether EUV dry photoresist technology, which was selected by a memory manufacturer as the production tool of record for its DRAM processes. Further, strengthening the company's position, the launch of ALTUS Halo, a novel ALD tool designed for molybdenum metallization in semiconductor production. The platform supported future scaling of semiconductor architectures, including 4F² DRAM and advanced GAA logic devices.
Further, it launched Akara, an advanced conductor etch system, launched in February 2025 alongside ALTUS Halo in a coordinated dual-product announcement. This addressed two complementary process steps in the advanced node manufacturing. Also, at the time of launch, it had already secured a tool of record selection at device manufacturers for various applications.
Excellence in Next Generation Technology Award
Nel ASA
Executive Summary
Nel ASA exemplifies excellence in next-generation technology within the green hydrogen electrolyzer industry. The company sustained its leadership in deploying next-gen technologies despite persistent market volatility. This stems from its intensive focus on technology-based R&D, capital optimization, and disciplined supply chain operations amid various challenges, including high costs, intense competition, shifts in government policies, and limited offtake agreements.
The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the green hydrogen domain using a combination of various indicators. These indicators, including capacity expansion trends, execution efficiency of capital expenditures, sustainability throughout operations, and the value of confirmed orders, were applied to leading green hydrogen companies to assess their performance. In line with this, Nel ASA launched a pressurized alkaline electrolyzer at its Heroya facility dedicated to electrolyzer manufacturing, aimed at reducing CapEx by 40%-60%, and levelized cost of hydrogen (LCOH) by 30%-40%.
Why This Company
Nel ASA has been nominated for the Excellence in Next Generation Technology Award for securing first-mover advantage by integrating pressurized alkaline electrolyzer technology, which overcomes the limitations of conventional electrolyzers while reducing CapEx and LCOH. Amid industry volatility, marked by the cancellation of the 40 MW project by Statkraft and FID delays that caused an over 28% annual revenue drop, Nel ASA secured funding from the EU innovation fund and responded with agility. It implemented strategies such as diversifying its product pipeline, adjusting production and workforce capacity, and focusing on advanced technologies. The company maintained its liquidity while enabling significant investment in technological advancement and capacity expansion. These strategies not only enable Nel ASA to navigate industry headwinds but also cement its position as a market-ready innovator.
Excellence in Operational AI Award
Siemens
Executive Summary
Siemens is nominated for the 2025 Excellence in Operational AI Award by BCC Research for advancing the application of AI in industrial operations. During 2025, the company continued its expansion of operational AI solutions for the manufacturing and industrial automation industry with its Industrial AI portfolio, its digital twin solutions, and its Industrial Copilot solutions as part of the Siemens Xcelerator ecosystem. Its use of AI-enabled digital twins and edge-based analytics helped factories simulate processes, detect inefficiencies in the factory operations, and improve the reliability of equipment.
The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation across companies implementing operational AI in industrial settings. Evaluation parameters included operational impact, system reliability, integration with existing operational systems, workforce enablement, and financial return from AI-driven automation. In accordance with this, Siemens recorded notable results in 2025 with the use of Industrial Copilot tools that aided engineering and production staff, AI-based predictive maintenance solutions that were connected to factory equipment, and flexible digital manufacturing solutions that were used in various industrial plants.
Why This Company
In 2025, Siemens expanded operational AI deployment across industrial environments through its Industrial AI portfolio and Siemens Xcelerator platform. New industrial AI solutions were unveiled by the company at the CES event, which was held in January 2025. The company’s industrial AI solutions employ the power of edge AI, digital twin, and software-defined automation to optimize industrial processes. With the help of industrial AI agents, unveiled by the company in January 2025, the company aimed to enable the automation of complex engineering and production processes. The company claimed that this technology has the potential to boost the productivity of industrial processes by as much as 50%.
Following the development of these technologies in 2025, Siemens also announced the release of new generative AI-based Industrial Copilot tools, which aided the engineering, maintenance, and production teams in the industrial value chain. The technology enabled engineers to create, debug, and develop programmable logic controller code using natural language, thus reducing the workload in the manufacturing process. Adoption of these AI tools expanded across multiple industrial customers, with more than 100 companies in Europe and the U.S. using Siemens Industrial Copilot technologies to improve operational efficiency and address labor shortages.
Excellence in Market Strategy
Toray
Executive Summary
Toray stands out in the market strategy award in the advanced material sector, with a key focus on carbon fibers. It demonstrates exceptional financial stability for the targeted segment, including broad product diversification and strong sustainability and future readiness. It sets the benchmark for other peers in the carbon fiber industry on how sustainable innovation can deliver environmental, social, and economic value on a global scale. The company operates an extensive global manufacturing and R&D network across Asia, North America, and Europe, spanning key industries such as aerospace, automotive, energy, electronics, and water treatment. In the carbon fiber market, Toray maintained a leading position with strong vertically integrated operations. It enables consistent product quality, secure supply, and strong collaboration across aviation, mobility, and renewable energy infrastructure. The company also prioritizes R&D investment with strong governance and sustainability practices.
The award assessment was based on a structured research methodology and process that combined market scanning, peer benchmarking, and scoring-based validation. The company's focus on strengthening production capacity, addressing product diversification needs, and expanding into multiple geographies supports its efforts to gain a strong foothold in market strategy. For instance, in 2025, Toray announced plans to increase the annual capacity of regular tow carbon fiber production by 20% to 35,000 metric tons to meet demand for pressure vessel applications in South Korea and the U.S.
Why This Company
Toray has a strong hold in the carbon fiber industry. Unlike diversified companies, where carbon fiber falls under composites or the advanced material category, Toray lists carbon fiber as a fully identified segment under the heading 'Carbon Fiber Composite Materials', where the core purpose and revenue source of the segment is carbon fiber, ensuring strategic investment and a long-term commitment to the sector. The company does not treat sustainability as a government-mandated regulation; instead, it integrates it directly into product design, financing structures, and customer outcomes.
Toray has recorded a minimal decline in overall revenue during April 2025 to December 2025 of 0.1% which can improve in the financial year reporting, hence assuming a positive revenue growth in FY25, similarly in the segment revenue, the company faced a decline of 4.7% during the same nine months period, owing to demand correction for the industrial applications of the product and a significant capital expenditure in projects by American and European facilities. Comparing Toray's performance with peers, it is struggling to sustain revenue momentum amid disruptions to end-user demand in sectors such as energy and electronics.
BCC Research Excellence Awards
Independent recognition backed by analyst-led evaluation and research-driven benchmarking. As the program evolves, this footer can support methodology content, the awards home page, and future News and Media coverage such as press releases.